Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Parkinson's disease | R-HSA-1643685 | 0 | mometasone | 441335 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | mometasone | 441335 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | mometasone | 441335 | drug-path |
| Glioma | Q9NZM4 | map05214 | dihydroergocristine | 107715 | drug-path |
| Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | dihydroergocristine | 107715 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | dihydroergocristine | 107715 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | dihydroergocristine | 107715 | drug-path |
| Fc epsilon RI signaling pathway | R-HSA-2454202 | map04664 | dihydroergocristine | 107715 | drug-path |
| VEGF signaling pathway | R-HSA-194138 | map04370 | dihydroergocristine | 107715 | drug-path |
| MAPK signaling pathway | R-HSA-9652817 | map04010 | dihydroergocristine | 107715 | drug-path |
| GnRH signaling pathway | R-HSA-168638 | map04912 | dihydroergocristine | 107715 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | raubasine | 5353 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | raubasine | 5353 | drug-path |
| Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | raubasine | 5353 | drug-path |
| Axon guidance | R-HSA-422475 | map04360 | raubasine | 5353 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | lobelanidine | 442646 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | lobelanidine | 442646 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | lobelanidine | 442646 | drug-path |
| Ubiquitin mediated proteolysis | R-HSA-983153 | map04120 | lobelanidine | 442646 | drug-path |
| Amyotrophic lateral sclerosis (ALS) | Q8NDH6-2 | 0 | lobelanidine | 442646 | drug-path |